Rockwell Medical Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 96/158 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 3.75.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Rockwell Medical Inc's Score
Industry at a Glance
Industry Ranking
96 / 158
Overall Ranking
247 / 4582
Industry
Pharmaceuticals
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
2
analysts
Buy
Current Rating
3.750
Target Price
+312.27%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Rockwell Medical Inc Highlights
StrengthsRisks
Rockwell Medical, Inc. is a healthcare company. The Company develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. The Company operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. The Company is the supplier of liquid and dry, acid and bicarbonate concentrates for dialysis patients in the United States. The Company manufactures hemodialysis concentrates at its facilities in Michigan, South Carolina, and Texas, and the Company manufactures its dry acid concentrate mixers at its facility in Iowa.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 39.39% year-on-year.
Fairly Valued
The company’s latest PE is -5.17, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 6.21M shares, decreasing 23.26% quarter-over-quarter.
Rockwell Medical, Inc. is a healthcare company. The Company develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. The Company operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. The Company is the supplier of liquid and dry, acid and bicarbonate concentrates for dialysis patients in the United States. The Company manufactures hemodialysis concentrates at its facilities in Michigan, South Carolina, and Texas, and the Company manufactures its dry acid concentrate mixers at its facility in Iowa.
Ticker SymbolRMTI
CompanyRockwell Medical Inc
CEOStrobeck (Mark)
Websitehttps://www.rockwellmed.com/
FAQs
What is the current price of Rockwell Medical Inc (RMTI)?
The current price of Rockwell Medical Inc (RMTI) is 0.849.
What is the symbol of Rockwell Medical Inc?
The ticker symbol of Rockwell Medical Inc is RMTI.
What is the 52-week high of Rockwell Medical Inc?
The 52-week high of Rockwell Medical Inc is 2.410.
What is the 52-week low of Rockwell Medical Inc?
The 52-week low of Rockwell Medical Inc is 0.780.
What is the market capitalization of Rockwell Medical Inc?
The market capitalization of Rockwell Medical Inc is 33.46M.
What is the net income of Rockwell Medical Inc?
The net income of Rockwell Medical Inc is -480.00K.
Is Rockwell Medical Inc (RMTI) currently rated as Buy, Hold, or Sell?
According to analysts, Rockwell Medical Inc (RMTI) has an overall rating of Buy, with a price target of 3.750.
What is the Earnings Per Share (EPS TTM) of Rockwell Medical Inc (RMTI)?
The Earnings Per Share (EPS TTM) of Rockwell Medical Inc (RMTI) is -0.164.